To further determine whether inhibiting ITK activity during the production of CAR-T cells could mimic ITK deletion, we investigated the effects of PF-06465469 (a potent ITK inhibitor that also inhibits BTK) and ibrutinib on CLL-CAR-T cells. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.